Leaderboards/Parkinson's Disease Mechanisms and Treatments

Parkinson's Disease Mechanisms and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Dongning Su
Capital Medical University
2
Brage Brakedal
Haukeland University Hospital
3
Corinne Quadalti
Technologies pour la Santé
4
Ann‐Kathrin Schalkamp
UK Dementia Research Institute
5
Varvara Mathiopoulou
Humboldt-Universität zu Berlin
6
Roberta Bovenzi
University of Rome Tor Vergata
7
Stephen Joza
University of Alberta
8
Bingkuan Xu
Nanjing Normal University
9
Sasivimol Virameteekul
Queen Mary University of London
10
Anastasia Kuzkina
Brigham and Women's Hospital

Papers

1
Publication in BMJ (2025) [418 citations, W4408208852]
BMJ|2025
418 cit.
2
Modulation of subthalamic beta oscillations by movement, dopamine, and deep brain stimulation in Parkinson’s disease
npj Parkinson s Disease|2024
90 cit.
3
Gamma entrainment induced by deep brain stimulation as a biomarker for motor improvement with neuromodulation
Nature Communications|2025
26 cit.
4
Sex differences in Parkinson’s disease-related non motor symptoms: a focus on sleep problems
Acta Neurologica Belgica|2024
21 cit.
5
Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease
npj Parkinson s Disease|2024
15 cit.
6
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder
EBioMedicine|2025
15 cit.
7
Publication in Journal of Neurology (2024) [13 citations, W4392880192]
Journal of Neurology|2024
13 cit.
8
Publication in Neurology (2024) [13 citations, W4399316341]
Neurology|2024
13 cit.
9
Publication in Journal of Neural Transmission (2024) [13 citations, W4400981364]
Journal of Neural Transmission|2024
13 cit.
10
Publication in Movement Disorders (2025) [9 citations, W4407945171]
Movement Disorders|2025
9 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Nicolas Dzamko
The University of Sydney
2
Matthias E. Lauer
Roche (Switzerland)
3
Lin Jiang
China Agricultural University
4
CM Tanner
University of California, San Francisco
5
Esther Sammler
University of Dundee
6
Clotilde Lagier‐Tourenne
Massachusetts General Hospital
7
Filip Scheperjans
University of Helsinki
8
Céline Galvagnion
University of Copenhagen
9
Ted Thompson
Michael J. Fox Foundation
10
Mei Cui
Huashan Hospital

Papers

1
Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
Brain|2022
144 cit.
2
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
Movement Disorders|2022
116 cit.
3
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease
Acta Neuropathologica|2024
64 cit.
4
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation
Nature Neuroscience|2023
49 cit.
5
Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
npj Parkinson s Disease|2022
44 cit.
6
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Scientific Reports|2023
39 cit.
7
Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease
npj Parkinson s Disease|2022
37 cit.
8
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
npj Parkinson s Disease|2023
37 cit.
9
Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals
Scientific Reports|2024
32 cit.
10
Education, neighborhood environment, and cognitive decline: Findings from two prospective cohort studies of older adults in China
Alzheimer s & Dementia|2022
30 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Virginia M.‐Y. Lee
Institute for Neurodegenerative Disorders
2
Andrew J. Lees
Centre for Movement Disorders
3
Matthew J. Farrer
University of Florida
4
Ted M. Dawson
Johns Hopkins University
5
Mauro Gemmi
Piaggio (Italy)
6
Yves Agid
Sorbonne Université
7
J. Timothy Greenamyre
University of Pittsburgh
8
Richard J. Youle
National Institutes of Health
9
Peter T. Lansbury
Harvard University
10
Dennis W. Dickson
Jacksonville College

Papers

1
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Scientific Reports|2016
13.3k cit.
2
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
Journal of Neurology Neurosurgery & Psychiatry|1992
10.4k cit.
3
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Science|2006
6.6k cit.
4
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
The Journal of Cell Biology|2008
4k cit.
5
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Nature Neuroscience|2000
3.7k cit.
6
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Brain|1991
3.5k cit.
7
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
PLoS Biology|2010
2.9k cit.
8
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Nature|2015
2.7k cit.
9
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Science|2012
2.6k cit.
10
Neurodegenerative Tauopathies
Annual Review of Neuroscience|2001
2.4k cit.

Reagents for Parkinson's Disease Mechanisms and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Santa Cruz BiotechnologyEvidence 65

alpha-synuclein (211)

Cited in 63 papers
#sc-12767
View Evidence →
BD BiosciencesEvidence 60

a-Synuclein

Cited in 50 papers
#610787
View Evidence →
Cell Signaling TechnologyEvidence 66

Cyclin A2 (E9Q5G) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 12 papers
#18676$865
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling Technology

PYURF (F9F4X) Rabbit Monoclonal Antibody

Cited in 39 papers
#16847$161,376
View Evidence →
Cell Signaling TechnologyEvidence 60

PathScan® Total HER4/ErbB4 Sandwich ELISA Kit

Cited in 35 papers
#13010$66,129,740
View Evidence →
Cell Signaling Technology

EXOSC2 (F6Y3J) Rabbit Monoclonal Antibody

Cited in 34 papers
#23542$161,376
View Evidence →

🌟 All-Time

Most validated

Santa Cruz BiotechnologyEvidence 65

alpha-synuclein (211)

Cited in 63 papers
#sc-12767
View Evidence →
BD BiosciencesEvidence 60

a-Synuclein

Cited in 50 papers
#610787
View Evidence →
Cell Signaling Technology

Phospho-SF3B1 (Thr313) (D8D8V) Rabbit Monoclonal Antibody

Cited in 44 papers
#25009$180,415
View Evidence →